跳至主要内容
临床试验/JPRN-UMIN000016535
JPRN-UMIN000016535已完成1 期

The study of the significance of the phosphorylation of p53 Ser46 in the prediction of response to preoperative chemotherapy or chemoradiotherapy for advanced esophageal cancer - The study of the significance of p53 Ser46-P in the prediction of response to preoperative treatment for advanced esophageal cancer

Kindai University, Faculty of Medicine, Department of Surgery0 个研究点目标入组 30 人开始时间: 2015年2月13日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

In this study, we examined the usefulness of induction of the phosphorylation of p53-Ser46 the next day after initiation of treatment as a biomarker of the prediction of treatment response of chemotherapy/chemoradiotherapy for esophageal squamous cell carcinoma. We confirmed the fact for the first time that the phosphorylation of p53-Ser-46 was induced by chemotherapy/chemoradiotherapy in the early stage of treatment. However, there was no significant correlation between the phosphorylation of p-53-Ser-46 and treatment response. Among cases obtained complete response to preoperative therapy, the cases with p-53 mutant and no induction of Ser-46 phosphorylation were involved, therefore, these results suggested that the effect on chemotherapy and chemoradiotherapy was caused not only by apoptosis thorough p53 pathway, but also by another pathway associating with other factors.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. another malignat disease to need treatment 2. past hostory of severe drug hypersensitivity 3. pregnant female, nursing mother and women who have childbearing potential and are considering pregnancy. 4. doctor rules unfit for enrollment of this study.

研究者

发起方
Kindai University, Faculty of Medicine, Department of Surgery

相似试验